166480 — Corestemchemon Share News
0.000.00%
- KR₩96bn
- KR₩131bn
- KR₩20bn
Brief: Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis
Brief: Corestemchemon To Divest 3.4 Billion Won Worth Of Own Shares
Brief: Corestemchemon To Divest 3.6 Billion Won Worth Of Own Shares
Brief: Corestemchemon To Divest 10.5 Billion Won Worth Of Own Shares
Brief: Corestemchemon To Divest 3.8 Billion Won Worth Of Own Shares
CEO
Brief: Corestem receives patent
Brief: Kadimastem signs memorandum of understanding with Corestem